Clinical Grade Human Adipose Tissue-Derived Mesenchymal Stem Cell Banking
Bagher Larijani1, Hamidreza Aghayan2, Parisa Goodarzi3
1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran Iran.
Acta Medica Iranica
|November 11, 2015
Summary
This study successfully produced clinical-grade mesenchymal stem cells from adipose tissue, meeting current good manufacturing practice (cGMP) standards for safe cell transplantation trials.
Area of Science:
- Regenerative Medicine
- Cell Therapy
Background:
- Adipose tissue-derived mesenchymal stem cells (AD-MSCs) hold therapeutic potential.
- Clinical applications require cells produced under stringent quality standards.
Purpose of the Study:
- To establish a reproducible method for generating GMP-grade AD-MSCs.
- To demonstrate the feasibility of preparing and banking clinical-grade AD-MSCs for transplantation.
Main Methods:
- Isolation and culture of AD-MSCs from five female donors.
- Characterization using standard cell biology methods.
- Karyotyping for chromosomal stability assessment.
Main Results:
- Consistent and reproducible cGMP-compliant AD-MSCs were established.
- High cell viability (mean 95.6%) and cell counts (mean 12.2x10^6/µL) were achieved.
- Chromosomal stability was confirmed through karyotyping.
Conclusions:
- Feasibility of preparing GMP-grade AD-MSCs demonstrated.
- Successful establishment of a process for clinical cell transplantation trials.
- AD-MSCs are a viable source for clinical-grade cell therapy products.
